M. Sleevi

Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose

David R. Clemmons, A C Moses, Andreas Sommer et al. · Growth Hormone & IGF Research · 2005 · 71 citations

Medicine, Endocrinology, Internal Medicine +16

Pharmacokinetic Studies of Recombinant Human Insulin-Like Growth Factor I (rhIGF-I)/rhIGF-Binding Protein-3 Complex Administered to Patients with Growth Hormone Insensitivity Syndrome

Cecilia Camacho‐Hübner, Stephen Rose, Michael A. Preece et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 50 citations · Full text

Medicine, Endocrinology, Pediatrics +17

Effects of Combined Recombinant Insulin-Like Growth Factor (IGF)-I and IGF Binding Protein-3 in Type 2 Diabetic Patients on Glycemic Control and Distribution of IGF-I and IGF-II among Serum Binding Protein Complexes

David R. Clemmons, M. Sleevi, G. Allan et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 36 citations

Medicine, Endocrinology, Pharmacotherapy +16

Recombinant, Nonglycosylated Human Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3) Is Degraded Preferentially after Administration to Type II Diabetics, Resulting in Increased Endogenous Glycosylated IGFBP-3

David R. Clemmons, M. Sleevi, Walker H. Busby · The Journal of Clinical Endocrinology & Metabolism · 2005 · 14 citations · Full text

Life Sciences, Biochemistry, Endocrinology +13